Aecon Group - President and CEO, Jean Louis Servranckx.
President and CEO, Jean Louis Servranckx.
Source: Aecon.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Aecon Group (ARE) is selling the roadbuilding division of its business to an Ontario company in a multi-million-dollar deal
  • The Vancouver-based commercial construction firm is selling the unit to Toronto-based Green Infrastructure Partners
  • The all-cash deal is worth $235 million
  • Aecon Transportation East provides roadbuilding infrastructure solutions across much of Ontario with public and private sector customers
  • Aecon Group (ARE) is up 15.48 per cent, trading at $11.71 per share

Aecon Group (ARE) is selling the roadbuilding division of its business in a multi-million-dollar deal.

The Vancouver-based commercial construction firm is selling Aecon Transportation East to Toronto-based Green Infrastructure Partners.

The all-cash deal is worth $235 million.

Aecon Transportation East provides roadbuilding infrastructure solutions across much of Ontario. Its clients include the provincial government, several municipalities, and private clients. The company employs around 1,000 people and accounted for around seven per cent of parent company Aecon’s consolidated revenue last year.

Aecon called the sale a move to streamline its operations and balance sheet.

“Aecon’s efforts are increasingly focused on helping meet its clients’ sustainable infrastructure needs and harnessing the opportunities that are expected to come from the transition to a net-zero economy through decarbonization,” said President and CEO, Jean-Louis Servranckx.

“This transaction is consistent with Aecon’s goal of targeting prudent balance sheet leverage and liquidity and also reduces the overall capital intensity of Aecon’s business,” he added.

Aecon Group (ARE) is up 15.48 per cent, trading at $11.71 per share at 11:02 am ET.


More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.